AMLX
Amylyx Pharmaceuticals Inc.
$13.10
+$0.03(+0.23%)
50
Overall
55
Value
50
Tech
47
Quality
Market Cap
$1.45B
Volume
829.80K
52W Range
$2.60 - $16.96
Target Price
$20.33
EPS Estimates Overview
| Current Quarter | $-0.34 | Next Quarter | $-0.4 |
| Current Year | $-1.48 | Next Year | $-1.21 |
| QoQ Growth | -17.6% | YoY Growth | +18.2% |
| 3Y EPS CAGR | -14.3% | Target Price | $20.33 |
| Consensus | Buy | Upside | +55.2% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AMLX | $13.10 | +0.2% | 829.80K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Amylyx Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW